Literature DB >> 19535949

Methods of cooling: practical aspects of therapeutic temperature management.

David B Seder1, Thomas E Van der Kloot.   

Abstract

OBJECTIVES: To review traditional and newer means of inducing, maintaining, and withdrawing therapeutic hypothermia and normothermia. To suggest treatment algorithms for temperature modulation and review neuromonitoring options.
DESIGN: A review of current literature describing methods of performing therapeutic temperature management and neuromonitoring during the cooling, maintenance, and decooling periods. Algorithms for performing therapeutic temperature management are suggested.
RESULTS: Temperature management can be safely and effectively performed using traditional or newer modalities. Although traditional means of cooling are feasible and efficacious, modern devices utilizing feedback loops to maintain steady body temperature and prevent overcooling have advantages in ease of application, patient safety, maintenance of target temperature, and control of decooling. Neuromonitoring options should be adapted to an individual patient and situation.
CONCLUSIONS: Intensivists should be familiar with techniques to induce, maintain, and withdraw therapeutic temperature management, and select the most appropriate method for a given patient and situation.

Entities:  

Mesh:

Year:  2009        PMID: 19535949     DOI: 10.1097/CCM.0b013e3181aa5bad

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

Review 1.  Therapeutic hypothermia for acute neurological injuries.

Authors:  Lucia Rivera-Lara; Jiaying Zhang; Susanne Muehlschlegel
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Treatment of resistant fever: new method of local cerebral cooling.

Authors:  Susanne Mink; Urs Schwarz; Regina Mudra; Christoph Gugl; Jürg Fröhlich; Emanuela Keller
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

3.  Therapeutic hypothermia for adult viral meningoencephalitis.

Authors:  Marko Kutleša; Bruno Baršić; Dragan Lepur
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

4.  Efficacy and Safety of Transnasal CoolStat Cooling Device to Induce and Maintain Hypothermia.

Authors:  Fabrizio R Assis; M Emma G Bigelow; Raghuram Chava; Sunjeet Sidhu; Aravindan Kolandaivelu; Henry Halperin; Harikrishna Tandri
Journal:  Ther Hypothermia Temp Manag       Date:  2018-09-20       Impact factor: 1.286

5.  Temperature elevation in epileptogenic foci exacerbates epileptic discharge through TRPV4 activation.

Authors:  Koji Shibasaki; Katsuya Yamada; Hideki Miwa; Yuchio Yanagawa; Michiyasu Suzuki; Makoto Tominaga; Yasuki Ishizaki
Journal:  Lab Invest       Date:  2019-10-22       Impact factor: 5.662

6.  Hemodynamic, Biochemical, and Ventilatory Parameters are Independently Associated with Outcome after Cardiac Arrest.

Authors:  Joseph H Pitcher; John Dziodzio; Joshua Keller; Teresa May; Richard R Riker; David B Seder
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

Review 7.  The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society.

Authors:  Lori Kennedy Madden; Michelle Hill; Teresa L May; Theresa Human; Mary McKenna Guanci; Judith Jacobi; Melissa V Moreda; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

8.  Surface cooling after cardiac arrest: effectiveness, skin safety, and adverse events in routine clinical practice.

Authors:  Salam Jarrah; John Dziodzio; Christine Lord; Gilles L Fraser; Lee Lucas; Richard R Riker; David B Seder
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

9.  Therapeutic hypothermia.

Authors:  Hing-Yu So
Journal:  Korean J Anesthesiol       Date:  2010-11-25

10.  Multimodality monitoring, inflammation, and neuroregeneration in subarachnoid hemorrhage.

Authors:  Adriano B Nogueira; Ariel B Nogueira; José C Esteves Veiga; Manoel J Teixeira
Journal:  Neurosurgery       Date:  2014-12       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.